Evidence map›Paper›PMID 33760639›Full record

ArticleJCO global oncology2021

Cancer and COVID-19 Experiences at African Cancer Centers: The Silver Lining.

Linda Grossheim, Paul Ruff, Twalib Ngoma, Verna Vanderpuye, Gladys Mwango, Primus Ochieng, Dennis Palmer, Francine Kouya, Nwamaka Lasebikan, Atara Ntekim and 6 more

Abstract read
In one paragraph

Article in JCO global oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Experiences of patients and providers while using telemedicine in cancer care during COVID-19 pandemic: a systematic review and meta-synthesis of qualitative literature.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  4. Article
  5. Democratizing FLASH Radiotherapy.Seminars in radiation oncology · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Linda GrossheimSummit Cancer Centers, Post Falls, ID.ORCID 0000-0003-2858-2623
Paul RuffUniversity of the Witwatersrand, Johannesburg, South Africa.
Twalib NgomaMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Verna VanderpuyeNational Center for Radiotherapy, Korlebu Teaching Hospital, Accra, Ghana.ORCID 0000-0003-3656-6965
Gladys MwangoUniversity of Nairobi, Nairobi, Kenya.ORCID 0000-0002-1386-4436
Primus OchiengUniversity of Nairobi, Nairobi, Kenya.
Dennis PalmerMbingo Baptist Hospital, Northwest, Cameroon.
Francine KouyaMbingo Baptist Hospital, Northwest, Cameroon.
Nwamaka LasebikanUniversity of Nigeria-Teaching Hospital, Enugu, Nigeria.ORCID 0000-0002-3775-0492
Atara NtekimUniversity College Hospital, Ibadan, Nigeria.
Mamsau NgomaOcean Road Cancer Institute, Dar es Salaam, Tanzania.ORCID 0000-0003-1382-8037
Noella BihDana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Abba MalloumNational Hospital, Bloemfontein, South Africa.
Ahmed ElzawawySuez Canal University, Ismailia, Egypt.ORCID 0000-0001-9266-0556
David KerrJohn Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Wilfred NgwaDana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Funding

Biomaterial Drones for Image-Guided Drug Delivery during radiotherapyR01CA239042 · NCI · JOHNS HOPKINS UNIVERSITY · PI NGWA, WILFRED · 2019 to 2023
$3.2M
NCI NIH HHS R01 CA239042
6 · The paper itself

Abstract

purposeThe COVID-19 pandemic significantly disrupted cancer care in Africa, further exposing major health disparities. This paper compares and contrasts the experiences of 15 clinicians in six different African cancer centers to highlight the positive aspects (silver linings) in an otherwise negative situation.

methodsData are from personal experience of the clinicians working at the six cancer centers blended with what is available in the literature.

resultsThe impact of COVID-19 on cancer care appeared to vary not only across the continent but also over cancer centers. Different factors such as clinic location, services offered, available resources, and level of restrictions imposed because of COVID-19 were associated with these variations. Collectively, delays in treatment and limited access to cancer care were commonly reported in the different regions.

conclusionThere is a lack of data on cancer patients with COVID-19 and online COVID-19 and cancer registries for Africa. Analysis of the available data, however, suggests a higher mortality rate for cancer patients with COVID-19 compared with those without cancer. Positive or silver linings coming out of the pandemic include the adoption of hypofractionated radiation therapy and teleoncology to enhance access to care while protecting patients and staff members. Increasing collaborations using online technology with oncology health professionals across the world are also being seen as a silver lining, with valuable sharing of experiences and expertise to improve care, enhance learning, and reduce disparities. Advanced information and communication technologies are seen as vital for such collaborations and could avail efforts in dealing with the ongoing pandemic and potential future crises.

Indexed as

Cancer Care FacilitiesCOVID-19NeoplasmsAfricaHealth Services AccessibilityHumans

Identifiers

PMID33760639
PMCPMC8081519

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.